As of June 19, 2025, Hong Kong ChaoShang Group Ltd (2322.HK) reports a Net Margin of -60.32%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Hong Kong ChaoShang Group Ltd's Net Margin
Over recent years, Hong Kong ChaoShang Group Ltd's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-03-31 | -60.32% |
| 2023-03-31 | -20.99% |
| 2022-03-31 | -15.85% |
| 2021-03-31 | -6.86% |
| 2020-03-31 | -8.16% |
This slight downward trend highlights how Hong Kong ChaoShang Group Ltd manages its overall profitability and cost control over time.
Comparing Hong Kong ChaoShang Group Ltd's Net Margin to Peers
To better understand Hong Kong ChaoShang Group Ltd's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Hong Kong ChaoShang Group Ltd (2322.HK) | -60.32% |
| Innovative Pharmaceutical Biotech Ltd (399.HK) | 1568.38% |
| Meilleure Health International Industry Group Ltd (2327.HK) | 64.09% |
| Wisdom Wealth Resources Investment Holding Group Ltd (7.HK) | 48.92% |
| China Pipe Group Ltd (380.HK) | 11.13% |
| CNNC International Ltd (2302.HK) | 10.59% |
Compared to its competitors, Hong Kong ChaoShang Group Ltd's Net Margin is among the lowest compared to peers, which may indicate challenges in controlling expenses or competitive pricing pressures.